Weight loss and psoriasis: the dietary change with high-certainty evidence, and what it does not promise

The recommendation nobody puts on a list

Psoriasis food advice is mostly about subtraction: gluten out, dairy out, nightshades out. The one piece of advice with evidence behind it does not fit that shape, which may be why it gets skipped. When the National Psoriasis Foundation's medical board reviewed 55 studies to write dietary recommendations, its only strong recommendation was dietary weight reduction with a hypocaloric diet in overweight and obese people with psoriasis; everything about specific foods was filed under low-quality data ^[2]. The current clinical-practice review for dermatologists puts it the same way: a low-calorie diet is often recommended for people who are overweight, and there is a strong association between obesity and psoriatic disease activity and progression ^[5].

That is the position of the people whose job is to weigh trials, and it is worth noticing how different its tone is from the internet's. No superfood, no forbidden list, and a defined population: people who are overweight or obese.

Sources for this section: [2] Dietary Recommendations for Adults With Psoriasis or Psoriatic Arthritis From the Medical Board of the National Psoriasis Foundation: A Systematic Review · [5] Nutrition and Psoriasis: The Latest Evidence and How to Approach Nutrition in Clinical Practice

The trial that showed it in people already on treatment

The most informative single study cited here is a randomised trial published in 2014. It took 303 overweight or obese patients with moderate-to-severe plaque psoriasis who had not cleared after four weeks of systemic treatment, and randomised them to a 20-week diet and exercise programme for weight loss or to a single session of advice about the value of losing weight ^[3].

The diet arm's median severity reduction was 48%, against 25.5% in the advice-only arm. A halving of the severity index was reached by 49.7% of the diet group against 34.2% of the advice group, and the weight-loss target of at least 5% of body weight was reached by 29.8% against 14.5% ^[3]. Read those figures together: fewer than a third of the diet arm hit the weight target, and the skin still improved more, which suggests the programme was doing something beyond the kilograms lost. The authors' conclusion was measured: a 20-week dietetic intervention with increased exercise reduced psoriasis severity in systemically treated overweight or obese patients with active psoriasis ^[3]. Alongside treatment, not instead of it.

Sources for this section: [3] Diet and physical exercise in psoriasis: a randomized controlled trial

Thirteen trials pooled: high certainty, modest size

In 2026 a systematic review pooled the randomised trials of weight-loss interventions in adults with psoriasis: thirteen trials, 1145 participants, eleven of them advising diet and three using weight-loss medication. Across the pooled comparisons, weight-loss interventions produced a greater reduction in severity than control, a mean difference of -2.5 on the severity index, and made a 75% improvement more likely, with a risk ratio of 1.6. Quality of life improved by a mean difference of -5.0 on the standard dermatology index. The authors rated the evidence high-certainty and concluded that weight-loss interventions should be considered part of routine treatment ^[4].

Two honest caveats sit inside that result. The effects on reaching a 50% or a complete clearance were not statistically significant, on few trials. And a mean difference of -2.5 is an average across trials whose results varied widely; it is a shift on the index, not a clearance. High certainty describes how sure the reviewers are that the effect is real, not how large it is.

Sources for this section: [4] Impact of weight-loss interventions on psoriasis severity: systematic review and meta-analysis

Where the Mediterranean trial fits

The other randomised diet trial this site's psoriasis guides lean on is the 2025 Mediterranean diet trial: 38 people with mild to moderate disease, 16 weeks of dietitian-guided Mediterranean eating against standard low-fat advice, a between-group improvement of -3.4 on the severity index, and nine of 19 in the diet arm reaching a 75% reduction against none of the controls ^[1]. It also found a significant reduction in glycated haemoglobin, the blood-sugar measure, in the diet group ^[1].

It was not a weight-loss trial, and it was in people with milder disease; its protocol prescribed no calorie target at all. But the two pieces of evidence do not conflict: the clinical-practice review recommends the Mediterranean pattern for people with psoriasis on the grounds of its anti-inflammatory effects and cardiovascular benefit, and a low-calorie diet for those who are overweight, in the same paragraph ^[5]. Whether one person should combine them is a question for the dietitian the trials used.

Sources for this section: [1] Mediterranean Diet and Patients With Psoriasis: The MEDIPSO Randomized Clinical Trial · [5] Nutrition and Psoriasis: The Latest Evidence and How to Approach Nutrition in Clinical Practice

Why the heart is the bigger reason

There is a second reason the recommendation exists, and it is not about skin. People with psoriasis and psoriatic arthritis are at significantly increased cardiovascular risk, attributed to chronic systemic inflammation and a high burden of cardiometabolic comorbidities, and those risk factors are frequently underdiagnosed and undertreated. The consensus recommendations for clinicians ask for cardiovascular risk assessment at diagnosis, routine screening for hypertension, diabetes, dyslipidaemia, smoking, obesity and metabolic syndrome, and lifestyle counselling on diet, exercise and weight management ^[6].

That is the frame the heart-first essay on this site argues for, and it changes what weight management is for. The plaques may improve, and the trials say on average they do. The cardiovascular consensus asks for weight management as part of lifestyle counselling whether or not they do.

Sources for this section: [6] Practical Recommendations on Cardiovascular Risk Evaluation in Patients With Psoriasis and Psoriatic Arthritis for Dermatologists, Rheumatologists, and Primary Care Physicians by the Psoriasis and Psoriatic Arthritis Clinics Multicenter Advancement Network

What this does not say

It does not say that everyone with psoriasis should lose weight. The trials were in people who were overweight or obese, and the recommendation is for that group. Nothing cited here is about people who are not.

It does not say that weight loss replaces treatment. The 303-patient trial was in people on systemic therapy, and the effect was on top of that therapy. The National Psoriasis Foundation's wording is that dietary interventions should always be used in conjunction with standard medical therapies ^[2]. And it does not say how to lose the weight; the pooled trials mostly advised dietary change, some with physical activity, and the 303-patient trial used a dietitian-planned diet with exercise ^[4].

The free seven-day psoriasis week on this site is the Mediterranean pattern with the portions and per-serving energy stated, so that anyone working with a dietitian on a calorie target can see what each meal contributes. It is food, not a weight-loss programme, and a person who needs one should ask for the dietitian the trials used. The pooled trials lost a mean of 6.7 kg more than their controls ^[4], over months, with professional support; that is the scale of change the evidence is about, and it is not a scale a week of recipes delivers on its own.

Sources for this section: [2] Dietary Recommendations for Adults With Psoriasis or Psoriatic Arthritis From the Medical Board of the National Psoriasis Foundation: A Systematic Review